These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9455057)

  • 21. Fasciola hepatica liver infection in a Victorian dairy farmer.
    Torresi J; Richards MJ; Taggart GJ; Smallwood RA
    Med J Aust; 1996 Apr; 164(8):511. PubMed ID: 8614357
    [No Abstract]   [Full Text] [Related]  

  • 22. Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures.
    Marcos L; Maco V; Terashima A
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):817-823. PubMed ID: 33267701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic fascioliasis resistant to bithionol treatment but responsive to triclabendazole].
    Medrano F; de Tomás E; Barba MA; Alamillo A; Ferreras P
    Enferm Infecc Microbiol Clin; 1999; 17(7):371-2. PubMed ID: 10535200
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatic fascioliasis: the usefulness of CT and US].
    Jiménez C; Jiménez FJ; Hoyos ML; Monllau A
    Rev Esp Enferm Dig; 1995 May; 87(5):397-8. PubMed ID: 7626300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis.
    Dobrucali A; Yigitbasi R; Erzin Y; Sunamak O; Polat E; Yakar H
    World J Gastroenterol; 2004 Oct; 10(20):3076-7. PubMed ID: 15378799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human case of invasive fascioliasis associated with liver abscess.
    Kim JB; Kim DJ; Huh S; Cho SY
    Korean J Parasitol; 1995 Dec; 33(4):395-8. PubMed ID: 8591020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel.
    Knobloch J; Delgado E; Alvarez A; Reymann U; Bialek R
    Trop Med Parasitol; 1985 Jun; 36(2):88-90. PubMed ID: 4023557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic fascioliasis in children: uncommon clinical manifestations].
    Almendras-Jaramillo M; Rivera-Medina J; Seijas-Mogrovejo J; Almendras-Jaramillo K
    Arq Gastroenterol; 1997; 34(4):241-7. PubMed ID: 9629320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione and related enzymes in fascioliasis before and after treatment with bithionol.
    Abdel-Rahman SZ; el-Sharkawy AM; Abou-Bacha LM; Salem A
    J Trop Med Hyg; 1990 Oct; 93(5):337-40. PubMed ID: 1977927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unsuccessful use of praziquantel to treat acute fascioliasis in children.
    Farid Z; Trabolsi B; Boctor F; Hafez A
    J Infect Dis; 1986 Nov; 154(5):920-1. PubMed ID: 2877032
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of acute toxaemic fascioliasis.
    Farid Z; Kamal M; Woody J
    Trans R Soc Trop Med Hyg; 1988; 82(2):299. PubMed ID: 2903590
    [No Abstract]   [Full Text] [Related]  

  • 32. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human fascioliasis: T cell subsets in liver before and after bithionol treatment.
    Abdel Rahman ZA; Fadali GA; Abou Basha LM
    J Egypt Soc Parasitol; 1990 Dec; 20(2):521-8. PubMed ID: 2230306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human fascioliasis: ultrastructural study on the liver before and after bithionol treatment.
    Abou Basha LM; Salem AI; Fadali GA
    J Egypt Soc Parasitol; 1990 Dec; 20(2):541-8. PubMed ID: 2230308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triclabendazole in the treatment of human fascioliasis: a review.
    Gandhi P; Schmitt EK; Chen CW; Samantray S; Venishetty VK; Hughes D
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):797-804. PubMed ID: 31638149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of fascioliasis hepatica with bithionol].
    Grados O; Berrocal LA
    Rev Inst Med Trop Sao Paulo; 1977; 19(6):425-7. PubMed ID: 613437
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fascioliasis: diagnosis, epidemiology and treatment].
    Carrada-Bravo T
    Rev Gastroenterol Mex; 2003; 68(2):135-42. PubMed ID: 15127652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fasciola hepatica infestation. Biopathology and new diagnostic and therapeutic aspects].
    de Górgolas M; Torres R; Verdejo C; Garay J; Robledo A; Ponte MC; Fernández Guerrero ML
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):514-9. PubMed ID: 1489790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antibodies and circulating excretory-secretory antigens for assessing cure in patients with fascioliasis.
    Espino AM; Millán JC; Finlay CM
    Trans R Soc Trop Med Hyg; 1992; 86(6):649. PubMed ID: 1287933
    [No Abstract]   [Full Text] [Related]  

  • 40. Single-day praziquantel therapy for neurocysticercosis.
    Corona T; Lugo R; Medina R; Sotelo J
    N Engl J Med; 1996 Jan; 334(2):125. PubMed ID: 8531958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.